Skip to content
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us

Monthly Sales-2025.03

 

Item Net Revenue
2025.03 731,508
2024.03 699,186
MoM Change 32,322
MoM Change (%) 4.62
2025 1-3 2,147,878
2024 1-3 2,042,061
YoY Change 105,817
YoY Change (%) 5.18
Note

 

PrevPREVIOUSAnnouncement on behalf of major subsidiary, Excelsior Healthcare Co., Limited, regarding BOD Resolution on dividend distribution.
NEXTThe Company is invited to attend an institutional investor conference hosted by President Securities on March 26, 2025.Next

Investors

Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us
  • 17F., No. 880, Zhongzheng Rd., Zhonghe Dist., New Taipei City, Taiwan
  • +886-2-2225-1888
[raiseup_copyright]